Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort CollaborationSophia M. Rein, Miguel A. Hernán, Alessandro Tavelli et al.|The Lancet HIV|2023Cited by 32
Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virusMathieu Chalouni, Sara Lodi, Daniela K van Santen et al.|AIDS|2025Cited by 2
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIVMathieu Chalouni, Sara Lodi, Jessie Torgersen et al.|AIDS|2026Cited by 0
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for Hepatitis C virus in people with HIV.Mathieu Chalouni, Sara Lodi, Jessie Torgersen et al.|Open Access CRIS of the University of Bern|2026Cited by 0
Risk of type 2 diabetes mellitus after treatment with direct-acting antivirals for hepatitis C virus in people with HIVMathieu Chalouni, Sara Lodi, Christopher T. Rentsch et al.|Unknown|2026Cited by 0